GeneLink, Inc. (GNLKQ)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Sep 2, 2025, 8:00 PM EDT
GeneLink Market Cap
GeneLink has a market cap or net worth of $10.60 thousand as of September 4, 2025. Its market cap has decreased by -86.67% in one year.
Market Cap
10.60K
Enterprise Value
n/a
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 17, 1999, GeneLink's market cap has decreased from 4.78M to 10.60K, a decrease of -99.78%. That is a compound annual growth rate of -20.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 10.60K | 3,900.38% |
| Dec 1, 2023 | 265.00 | - |
| Dec 22, 2022 | 265.00 | - |
| Dec 31, 2021 | 265.00 | -99.86% |
| Dec 31, 2020 | 185.51K | 40.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 891.61M |
| Elite Pharmaceuticals | 751.15M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 631.79M |
| CytoDyn | 401.20M |
| Northwest Biotherapeutics | 394.86M |
| American Oncology Network | 353.52M |